DEA to Temporarily Schedule 7-OH

The United States Drug Enforcement Administration (DEA) recently filed its intent to temporarily place 7-hydroxymitagynine (7-OH) into Schedule 1 of the Controlled Substances Act. 7-OH has no accepted medical use and high potential for abuse. 7-OH products are easily available and can be found online and in gas stations, vape shops, and convenience stores.

Health effects associated with the use of 7-OH products include anxiety, depression, gastrointestinal distress, insomnia, and seizures. 7-Oh can be addictive and users may experience withdrawals symptoms such as restlessness, body aches, fatigue, irritability, and cold sweats.

The temporary scheduling will go into effect likely in early August 2026.

For more information, visit:

DEA to Temporarily Schedule 7-OH and Related Substances to Protect Public Safety

Products Containing 7-OH Can Cause Serious Harm | FDA

FDA Recommends Restricting 7-OH Products

The United States Food and Drug Administration (FDA) is recommending that the substance 7-hydroxymitragynine, known as 7-OH, become a controlled substance due to its ability to bind to opioid receptors, making it potentially addictive. 7-OH is a concentrated component of the kratom plant. The FDA is focused on regulating 7-OH and not focused on natural kratom products.

The use and availability of 7-OH products is growing at a concerning rate. The FDA has not approved any 7-OH drugs or 7-OH dietary supplements and 7-OH cannot be lawfully added to food. Fruit flavored gummies and ice cream cones that contain 7-OH are especially appealing to children and teenagers. The Drug Enforcement Administration is reviewing FDA’s recommendation to make 7-OH a controlled substance and will make a final decision later.

For more information:

FDA News Release: https://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers

VDH Kratom Factsheet: https://www.vdh.virginia.gov/environmental-health/public-health-toxicology/kratom/

FDA 7-OH Product Page: https://www.fda.gov/drugs/information-consumers-and-patients-drugs/hiding-plain-sight-7-oh-products